Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database

Fig. 3

Selection of first-line AD therapy for drug-naive patients with T2DM in the outpatient setting. AD antidiabetes drugs, DPP-4 dipeptidyl peptidase-4, GI glucosidase inhibitor, GLP-1 RA glucagon like peptide-1 receptor agonist, SGLT-2 sodium glucose co-transporter-2, SU sulfonylurea, T2DM type 2 diabetes mellitus, TZD thiazolidinediones

Back to article page